Iqvia Holdings Inc. - Understand $iqv stock

$IQV Market Cap: $36.88 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$15.32B

TTM

Gross Margin

26.05%

TTM

Net Earnings

$1.405B

TTM

Current Assets

$5.632B

Q3 2024

Current Liabilities

$6.992B

Q3 2024

Current Ratio

80.55%

Q3 2024

Total Assets

$27.18B

Q3 2024

Total Liabilities

$20.21B

Q3 2024

Book Value

$6.967B

Q3 2024

Cash

$1.572B

Q3 2024

P/E

26.25

Nov 29, 2024 EST

Free Cash Flow

$1.961B

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue	$14.98B	$14.41B	$13.87B	$11.36B	$11.09B	$10.41B	$9.702B	$6.878B	$5.737B	$5.460B	$5.100B	$4.866B	$4.328B	$3.924B	$3.900B
YoY Change	3.98%	3.86%	22.14%	2.44%	6.49%	7.32%	41.06%	19.89%	5.07%	7.07%	4.81%	12.43%	10.29%	0.62%	3.67%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue	$14.98B	$14.41B	$13.87B	$11.36B	$11.09B	$10.41B	$9.702B	$6.878B	$5.737B	$5.460B	$5.100B	$4.866B	$4.328B	$3.924B	$3.900B
Cost Of Revenue	$9.745B	$9.382B	$9.233B	$7.500B	$7.300B	$6.746B	$4.622B	$3.236B	$2.705B	$2.664B	$2.471B	$2.459B	$2.153B	$2.805B	$2.784B
Gross Profit	$5.239B	$5.028B	$4.641B	$3.859B	$3.788B	$3.666B	$5.080B	$3.642B	$3.032B	$2.796B	$2.628B	$2.406B	$2.175B	$1.119B	$1.116B
Gross Profit Margin	34.96%	34.89%	33.45%	33.97%	34.16%	35.21%	52.36%	52.95%	52.85%	51.21%	51.54%	49.45%	50.25%	28.52%	28.62%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Selling, General & Admin	$2.053B	$2.071B	$1.964B	$1.789B	$1.734B	$1.716B	$1.622B	$1.011B	$815.0M	$781.0M	$860.5M	$817.8M	$762.3M	$698.0M	$684.0M
YoY Change	-0.87%	5.45%	9.78%	3.17%	1.05%	5.8%	60.44%	24.05%	4.35%	-9.24%	5.23%	7.27%	9.21%	2.05%	-0.73%
% of Gross Profit	39.19%	41.19%	42.32%	46.36%	45.78%	46.81%	31.93%	27.76%	26.88%	27.93%	32.74%	33.99%	35.05%	62.38%	61.29%
Research & Development									$3.337M	$5.791M	$4.955M	$10.43M	$9.986M
YoY Change									-42.38%	16.87%	-52.47%	4.41%
% of Gross Profit									0.11%	0.21%	0.19%	0.43%	0.46%
Depreciation & Amortization	$1.125B	$1.130B	$1.264B	$1.287B	$1.202B	$1.141B	$1.011B	$289.0M	$128.0M	$121.0M	$107.5M	$98.29M	$92.00M	$93.20M
YoY Change	-0.44%	-10.6%	-1.79%	7.07%	5.35%	12.86%	249.83%	125.78%	5.79%	12.55%	9.38%	6.83%	-1.28%
% of Gross Profit	21.47%	22.47%	27.24%	33.35%	31.73%	31.12%	19.9%	7.94%	4.22%	4.33%	4.09%	4.08%	4.23%	8.33%
Operating Expenses	$2.053B	$2.071B	$1.964B	$1.789B	$1.734B	$1.716B	$1.622B	$1.011B	$818.3M	$786.8M	$865.5M	$828.2M	$772.3M	$698.0M	$684.0M
YoY Change	-0.87%	5.45%	9.78%	3.17%	1.05%	5.8%	60.44%	23.54%	4.01%	-9.09%	4.5%	7.24%	10.64%	2.05%	-0.73%
Operating Profit	$1.977B	$1.799B	$1.393B	$731.0M	$777.0M	$741.0M	$665.0M	$642.0M	$646.0M	$590.0M	$462.3M	$396.4M	$345.3M	$421.0M	$432.0M
YoY Change	9.89%	29.15%	90.56%	-5.92%	4.86%	11.43%	3.58%	-0.62%	9.49%	27.61%	16.62%	14.83%	-17.99%	-2.55%	35.85%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Interest Expense	$672.0M	$416.0M	$375.0M	$416.0M	$447.0M	$414.0M	-$339.0M	$144.0M	$101.0M	$101.0M	$123.5M	-$134.4M	$109.1M	-$156.0M	-$106.0M
YoY Change	61.54%	10.93%	-9.86%	-6.94%	7.97%	-222.12%	-335.42%	42.57%	0.0%	-18.22%	-191.92%	-223.2%	-169.91%	47.17%	-21.48%
% of Operating Profit	33.99%	23.12%	26.92%	56.91%	57.53%	55.87%	-50.98%	22.43%	15.63%	17.12%	26.71%	-33.89%	31.59%	-37.05%	-24.54%
Other Income/Expense, Net	$124.0M	-$33.00M	$130.0M	$65.00M	$37.00M	-$5.000M	-$13.00M	$8.000M	-$2.000M	$8.000M	$185.0K	$3.572M	-$9.073M	$2.000M	-$10.00M
YoY Change	-475.76%	-125.38%	100.0%	75.68%	-840.0%	-61.54%	-262.5%	-500.0%	-125.0%	4224.32%	-94.82%	-139.37%	-553.65%	-120.0%	-166.67%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Pretax Income	$1.459B	$1.363B	$1.128B	$373.0M	$352.0M	$328.0M	$294.0M	$479.0M	$539.0M	$501.0M	$323.1M	$267.4M	$184.7M	$242.0M	$301.0M
YoY Change	7.04%	20.83%	202.41%	5.97%	7.32%	11.56%	-38.62%	-11.13%	7.58%	55.05%	20.82%	44.81%	-23.69%	-19.6%	103.38%
Income Tax	$101.0M	$260.0M	$163.0M	$72.00M	$116.0M	$59.00M	-$992.0M	$345.0M	$159.0M	$149.0M	$95.97M	$93.36M	$15.11M	$78.00M	$88.00M
% Of Pretax Income	6.92%	19.08%	14.45%	19.3%	32.95%	17.99%	-337.41%	72.03%	29.5%	29.74%	29.7%	34.91%	8.18%	32.23%	29.24%
Net Earnings	$1.358B	$1.091B	$966.0M	$279.0M	$191.0M	$259.0M	$1.277B	$115.0M	$387.0M	$357.0M	$226.6M	$177.5M	$241.8M	$161.0M	$210.0M
YoY Change	24.47%	12.94%	246.24%	46.07%	-26.25%	-79.72%	1010.43%	-70.28%	8.4%	57.55%	27.62%	-26.56%	50.17%	-23.33%	500.0%
Net Earnings / Revenue	9.06%	7.57%	6.96%	2.46%	1.72%	2.49%	13.16%	1.67%	6.75%	6.54%	4.44%	3.65%	5.59%	4.1%	5.38%
Basic Earnings Per Share	$7.39	$5.82	$5.05	$1.46	$0.98	$1.27	$5.86	$0.77	$3.15	$2.78	$1.83	$1.53	$2.08
Diluted Earnings Per Share	$7.29	$5.72	$4.95	$1.43	$0.96	$1.24	$5.74	$0.76	$3.08	$2.72	$1.77	$1.51	$2.05	$1.364M	$1.780M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Cash & Short-Term Investments	$1.496B	$1.309B	$1.477B	$1.902B	$899.0M	$938.0M	$1.005B	$1.238B	$1.078B	$986.0M	$870.0M	$637.0M	$563.0M
YoY Change	14.29%	-11.37%	-22.34%	111.57%	-4.16%	-6.67%	-18.82%	14.84%	9.33%	13.33%	36.58%	13.14%
Cash & Equivalents	$1.376B	$1.216B	$1.366B	$1.814B	$837.0M	$891.0M	$959.0M	$1.198B	$977.0M	$867.0M	$778.0M	$568.0M	$516.0M
Short-Term Investments	$120.0M	$93.00M	$111.0M	$88.00M	$62.00M	$47.00M	$46.00M	$40.00M	$101.0M	$119.0M	$92.00M	$69.00M	$47.00M
Other Short-Term Assets	$687.0M	$712.0M	$677.0M	$722.0M	$589.0M	$473.0M	$405.0M	$358.0M	$134.0M	$140.0M	$135.0M	$110.0M	$86.00M
YoY Change	-3.51%	5.17%	-6.23%	22.58%	24.52%	16.79%	13.13%	167.16%	-4.29%	3.7%	22.73%	27.91%
Inventory
Prepaid Expenses
Receivables	$3.381B	$2.917B	$2.551B	$2.410B	$2.582B	$2.394B	$2.097B	$1.707B	$1.166B	$975.0M	$924.0M	$745.0M	$691.0M
Other Receivables	$32.00M	$43.00M	$58.00M	$56.00M	$56.00M	$69.00M	$47.00M	$34.00M	$34.00M	$46.00M	$16.00M	$18.00M	$25.00M
Total Short-Term Assets	$5.596B	$4.981B	$4.763B	$5.090B	$4.126B	$3.874B	$3.554B	$3.337B	$2.412B	$2.146B	$1.946B	$1.510B	$1.365B
YoY Change	12.35%	4.58%	-6.42%	23.36%	6.5%	9.0%	6.5%	38.35%	12.4%	10.28%	28.87%	10.62%
Property, Plant & Equipment	$819.0M	$863.0M	$903.0M	$953.0M	$954.0M	$434.0M	$440.0M	$406.0M	$188.0M	$190.0M	$200.0M	$194.0M	$186.0M
YoY Change	-5.1%	-4.43%	-5.25%	-0.1%	119.82%	-1.36%	8.37%	115.96%	-1.05%	-5.0%	3.09%	4.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$239.0M	$162.0M	$164.0M	$162.0M	$152.0M	$142.0M	$78.00M	$82.00M	$85.00M	$66.00M	$63.00M	$55.00M	$34.00M
YoY Change	47.53%	-1.22%	1.23%	6.58%	7.04%	82.05%	-4.88%	-3.53%	28.79%	4.76%	14.55%	61.76%
Other Assets	$621.0M	$590.0M	$615.0M	$500.0M	$346.0M	$348.0M	$344.0M	$266.0M	$153.0M	$149.0M	$151.0M	$165.0M	$190.0M
YoY Change	5.25%	-4.07%	23.0%	44.51%	-0.57%	1.16%	29.32%	73.86%	2.68%	-1.32%	-8.48%	-13.16%
Total Long-Term Assets	$21.09B	$20.36B	$19.93B	$19.47B	$19.13B	$18.68B	$19.30B	$17.87B	$1.514B	$1.150B	$1.121B	$989.0M	$958.0M
YoY Change	3.58%	2.16%	2.32%	1.82%	2.41%	-3.25%	8.01%	1080.38%	31.65%	2.59%	13.35%	3.24%
Total Assets	$26.68B	$25.34B	$24.69B	$24.56B	$23.25B	$22.55B	$22.86B	$21.21B	$3.926B	$3.296B	$3.067B	$2.499B	$2.323B
YoY Change
Accounts Payable	$3.564B	$645.0M	$621.0M	$581.0M	$575.0M	$437.0M	$322.0M	$250.0M	$145.0M	$842.0M	$101.0M	$85.00M	$70.00M
YoY Change	452.56%	3.86%	6.88%	1.04%	31.58%	35.71%	28.8%	72.41%	-82.78%	733.66%	18.82%	21.43%
Accrued Expenses	$2.631B	$2.414B	$2.189B	$2.116B	$1.855B	$1.638B	$1.485B	$1.325B	$691.0M		$761.0M	$658.0M	$617.0M
YoY Change	8.99%	10.28%	3.45%	14.07%	13.25%	10.3%	12.08%	91.75%			15.65%	6.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$718.0M	$157.0M	$100.0M	$149.0M	$100.0M	$100.0M	$103.0M	$92.00M	$49.00M	$1.000M	$10.00M	$56.00M	$20.00M
YoY Change	357.32%	57.0%	-32.89%	49.0%	0.0%	-2.91%	11.96%	87.76%	4800.0%	-90.0%	-82.14%	180.0%
Total Short-Term Liabilities	$6.491B	$5.578B	$5.241B	$4.558B	$3.945B	$3.534B	$3.156B	$2.705B	$1.594B	$1.472B	$1.482B	$1.309B	$1.192B
YoY Change	16.37%	6.43%	14.98%	15.54%	11.63%	11.98%	16.67%	69.7%	8.29%	-0.67%	13.22%	9.82%
Long-Term Debt	$12.96B	$12.82B	$12.21B	$12.51B	$11.55B	$10.91B	$10.12B	$7.108B	$2.419B	$2.283B	$2.036B	$2.366B	$1.952B
YoY Change	1.06%	4.98%	-2.36%	8.32%	5.85%	7.76%	42.4%	193.84%	5.96%	12.13%	-13.95%	21.21%
Other Long-Term Liabilities	$921.0M	$711.0M	$785.0M	$882.0M	$852.0M	$418.0M	$440.0M	$402.0M	$183.0M	$184.0M	$179.0M	$171.0M	$139.0M
YoY Change	29.54%	-9.43%	-11.0%	3.52%	103.83%	-5.0%	9.45%	119.67%	-0.54%	2.79%	4.68%	23.02%
Total Long-Term Liabilities	$13.88B	$13.53B	$13.00B	$13.39B	$12.40B	$11.33B	$10.56B	$7.510B	$2.602B	$2.467B	$2.215B	$2.537B	$2.091B
YoY Change	2.56%	4.11%	-2.93%	7.99%	9.47%	7.22%	40.64%	188.62%	5.47%	11.38%	-12.69%	21.33%
Total Liabilities	$20.57B	$19.57B	$18.65B	$18.56B	$17.25B	$15.84B	$14.86B	$12.58B	$4.491B	$4.000B	$3.734B	$3.859B	$3.293B
YoY Change	5.09%	4.96%	0.45%	7.62%	8.92%	6.55%	18.19%	180.0%	12.28%	7.12%	-3.24%	17.19%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Basic Shares Outstanding	183.8M shares	187.6M shares	191.4M shares	191.3M shares	195.1M shares	203.7M shares	217.8M	149.1M	123.0M	128.0M shares	124.1M	115.7M shares	116.2M shares
Diluted Shares Outstanding	186.3M shares	190.6M shares	195.0M shares	195.0M shares	199.6M shares	208.2M shares	222.6M	152.0M	125.6M	131.1M shares	127.9M	117.8M shares	117.9M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $36.875 Billion

About IQVIA HOLDINGS INC.

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 88,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.

Industry: Services-Commercial Physical & Biological Research Peers: AGILENT TECHNOLOGIES, INC. Avantor, Inc. DANAHER CORP /DE/ REVVITY, INC. ILLUMINA, INC. METTLER TOLEDO INTERNATIONAL INC/ THERMO FISHER SCIENTIFIC INC. WEST PHARMACEUTICAL SERVICES INC WATERS CORP /DE/